Is Bluejay Diagnostics, Inc. (BJDX) Halal?

NASDAQ Healthcare United States $2M
✗ NOT HALAL
Confidence: 83/100
Bluejay Diagnostics, Inc. (BJDX) is Not Halal under AAOIFI Standard 21. While the debt ratio of 12.3% is acceptable, the cash and interest-bearing securities ratio of 238.0% exceeds the 30% threshold. Bluejay Diagnostics, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 12.3%
/ 30%
238.0%
/ 30%
0.0%
/ 30%
N/A ✗ NOT HALAL
DJIM 12.3%
/ 33%
238.0%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
MSCI 3.3%
/ 33%
64.6%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
S&P 12.3%
/ 33%
238.0%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
FTSE 3.3%
/ 33%
64.6%
/ 33%
0.0%
/ 50%
N/A ✗ NOT HALAL

Financial Highlights

EPS
$-15.25
P/B Ratio
0.2
EV/EBITDA
0.5
EV: -$3M
Revenue
$0
Beta
0.7
Low volatility
Current Ratio
4.9

Profitability

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Return on Equity (ROE) -117.0%
Return on Assets (ROA) -62.8%

Cash Flow & Balance Sheet

Operating Cash Flow-$6M
Free Cash Flow-$6M
Total Debt$120,211
Debt-to-Equity2.2
Current Ratio4.9
Total Assets$7M

Price & Trading

Last Close$1.98
50-Day MA$2.47
200-Day MA$5.20
Avg Volume237K
Beta0.7
52-Week Range
$1.70
$40.80

About Bluejay Diagnostics, Inc. (BJDX)

CEO
Mr. Indranil Dey
Employees
6
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$2M
Currency
USD

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Bluejay Diagnostics, Inc. (BJDX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Bluejay Diagnostics, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Bluejay Diagnostics, Inc.'s debt ratio?

Bluejay Diagnostics, Inc.'s debt ratio is 12.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.3%.

What are Bluejay Diagnostics, Inc.'s key financial metrics?

Bluejay Diagnostics, Inc. has a market capitalization of $2M. Return on equity stands at -117.0%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.